search

Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) have succeeded in turning human stem cells from skin samples into “tiny, three-dimensional, brain-like cultures”. 

The LCSB, part of the University of Luxembourg, said the cultures behaved “very similarly” to cells in the human midbrain.

They said they had succeeded in getting various cell types to develop, connect, exchange signals and “produce metabolic products typical of the active brain”.

Professor Jens Schwamborn, in whose research group the work was done, said: “Our cell cultures open new doors to brain research. “We can now use them to study the causes of Parkinson’s disease and how it could possibly be effectively treated.”

The human “midbrain” – particularly the structure known as the substantia nigra – is of great interest in the fight against Parkinson’s. Researchers are unable to remove cells from this region of the brain for study due to ethical concerns. But the work done at the LCSB may help researchers to resolve this problem.

 

Read more

Rotarex invests in Luxembourg production capacity and R&D

02-03-2021

The COVID-19 pandemic has led to a sharp increase in the demand for medical products from Rotarex. In order to meet the increased demand, the company has invested in new production lines and launched three new R&D projects. Both initiatives have received support from the Luxembourg government.
Read more

The health technology sector facing COVID-19

24-02-2021

The annual event organised by the Luxembourg HealthTech Cluster of Luxinnovation will present testimonials from companies.
Read more

COVID-19 vaccination: Innovative cold chain solutions

18-02-2021

Luxembourg-based healthtech company B Medical Systems specialises in vaccine cold chain solutions and medical refrigeration. With recent innovations making its vaccine freezers more flexible and resilient, the company is playing a key role in the fight against COVID-19. Its international client portfolio, head count and production facilities are all expanding rapidly.
Read more

Luxembourg to open healthtech incubator

22-01-2021

Luxembourg's new business health technologies incubator will open in spring 2021. Hosted at the House of Biohealth in Esch-Belval, it will offer 350 m2 of laboratory space to start-ups and spin-offs during their first 2-3 years of operation.
Read more

Korean biotech MBD sets up joint research laboratory in Luxembourg

20-01-2021

South Korean MBD is setting up a joint laboratory with the Luxembourg Institute of Health (LIH) and the Integrated Biobank of Luxembourg (IBBL). The laboratory will focus on precision medicine for cancer patients. MBD will also use its new base in Luxembourg to expand its business in Europe.
Read more

All news

Fermer